Alignment Healthcare (ALHC) to Release Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, May 2nd. Analysts expect Alignment Healthcare to post earnings of ($0.24) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual interested in registering for the company's earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.03). The firm had revenue of $465.39 million for the quarter, compared to analyst estimates of $444.56 million. Alignment Healthcare had a negative net margin of 8.12% and a negative return on equity of 75.64%. The business's revenue was up 28.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.31) EPS. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alignment Healthcare Stock Performance

NASDAQ:ALHC traded down $0.02 during mid-day trading on Thursday, hitting $5.16. The stock had a trading volume of 439,183 shares, compared to its average volume of 867,510. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 1.02. The company has a 50 day simple moving average of $5.25 and a 200-day simple moving average of $6.61. The stock has a market capitalization of $975.14 million, a price-to-earnings ratio of -6.53 and a beta of 1.30. Alignment Healthcare has a 52 week low of $4.46 and a 52 week high of $9.20.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several analyst reports. Raymond James boosted their price objective on Alignment Healthcare from $10.00 to $12.00 and gave the stock a "strong-buy" rating in a research report on Tuesday, January 9th. UBS Group reduced their price objective on shares of Alignment Healthcare from $9.00 to $8.50 and set a "neutral" rating for the company in a report on Wednesday, February 28th. Stifel Nicolaus lowered their target price on shares of Alignment Healthcare from $11.00 to $9.00 and set a "buy" rating on the stock in a research note on Tuesday. William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. Finally, Stephens increased their price objective on shares of Alignment Healthcare from $10.00 to $10.50 and gave the company an "equal weight" rating in a report on Tuesday, January 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $9.18.

Insider Activity at Alignment Healthcare

In related news, CFO Robert Thomas Freeman sold 28,522 shares of the firm's stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $5.05, for a total transaction of $144,036.10. Following the completion of the sale, the chief financial officer now directly owns 869,706 shares in the company, valued at $4,392,015.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CFO Robert Thomas Freeman sold 28,522 shares of the business's stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $5.05, for a total transaction of $144,036.10. Following the sale, the chief financial officer now directly owns 869,706 shares of the company's stock, valued at $4,392,015.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John E. Kao bought 103,000 shares of Alignment Healthcare stock in a transaction dated Thursday, March 14th. The shares were bought at an average cost of $4.82 per share, with a total value of $496,460.00. Following the completion of the acquisition, the chief executive officer now owns 2,745,253 shares of the company's stock, valued at $13,232,119.46. The disclosure for this purchase can be found here. Insiders sold a total of 90,213 shares of company stock valued at $460,587 over the last ninety days. Insiders own 6.30% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.